Table 2.
Correlation analysis of ACTBL2 expression and clinicopathological data.
| Variables | Combined ACTBL2 expression | |
|---|---|---|
| p | Correlation coefficient | |
| Histology | ||
| serous | 0.013* | 0.213 |
| clear cell | 0.044* | -0.174 |
| endometrioid | 0.176 | -0.118 |
| mucinous | 0.640 | -0.041 |
| FIGO | 0.728 | 0.031 |
| pT | 0.150 | 0.126 |
| pN | 0.883 | 0.016 |
| Grading | ||
| serous – low grading | 0.098 | -0.144 |
| serous – high grading | 0.003* | 0.253 |
| clear cell, endometrioid and mucinous – G1 to G3 | 0.589 | 0.096 |
Spearman’s correlation analysis of combined cytoplasmic (IRS>2) and membranous (IRS>0) ACTBL2 expression and clinicopathological characteristics, showing a positive correlation between positive ACTBL2 expression, serous histology (p=0.013, Cc=0.213) and high grading of serous carcinoma (p=0.003, Cc=0.253), respectively. Significant correlations are indicated with asterisks (*p < 0.05).
(p=two-tailed significance, Cc=correlation coefficient).